Prestige Consumer Healthcare Inc. (NYSE:PBH) CEO Ronald M. Lombardi Sells 10,875 Shares

Prestige Consumer Healthcare Inc. (NYSE:PBH) CEO Ronald M. Lombardi sold 10,875 shares of the firm’s stock in a transaction that occurred on Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total value of $898,275.00. Following the completion of the sale, the chief executive officer now owns 320,952 shares in the company, valued at approximately $26,510,635.20. This represents a 3.28 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE PBH traded up $1.47 during mid-day trading on Thursday, reaching $84.14. 286,632 shares of the company were exchanged, compared to its average volume of 251,540. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $4.16 billion, a P/E ratio of 20.11, a P/E/G ratio of 2.32 and a beta of 0.47. The company’s 50-day simple moving average is $73.91 and its 200-day simple moving average is $70.48. Prestige Consumer Healthcare Inc. has a twelve month low of $56.61 and a twelve month high of $84.21.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.09. The business had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. Prestige Consumer Healthcare’s quarterly revenue was down .9% on a year-over-year basis. During the same quarter last year, the firm earned $1.07 earnings per share. As a group, research analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current year.

Institutional Investors Weigh In On Prestige Consumer Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of PBH. Opal Wealth Advisors LLC purchased a new position in Prestige Consumer Healthcare in the 2nd quarter worth approximately $26,000. Quest Partners LLC raised its stake in Prestige Consumer Healthcare by 2,826.7% during the 2nd quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after buying an additional 424 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after acquiring an additional 208 shares during the period. Gladius Capital Management LP bought a new position in Prestige Consumer Healthcare in the 2nd quarter worth approximately $35,000. Finally, Northwestern Mutual Wealth Management Co. lifted its position in shares of Prestige Consumer Healthcare by 562.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock worth $35,000 after buying an additional 433 shares in the last quarter. Institutional investors own 99.95% of the company’s stock.

Analyst Ratings Changes

PBH has been the subject of a number of analyst reports. Jefferies Financial Group reaffirmed a “hold” rating and set a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson reissued a “buy” rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $83.67.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.